Fax completed prior authorization request form to 800-854-7614 or submit Electronic Prior Authorization through
CoverMyMeds® or SureScripts.
All requested data must be provided. Incomplete forms or forms without the chart notes will be returned
Pharmacy Coverage Guidelines are available at
www.mercycareaz.org/providers/completecare-
forproviders/pharmacy
Spravato Nasal Spray
Pharmacy Prior Authorization Request Form
Do not copy for future use. Forms are updated frequently.
REQUIRED: Office notes, labs and medical testing relevant to request showing medical justification to support diagnosis
Member Name (first & last):
Prescribing Provider Information
Provider Name (first & last):
Dispensing Pharmacy Information
Requested Medication Information
Medication request is NOT for an FDA- approved, or
compendia-supported diagnosis (circle one): Yes No
Are there any contraindications to formulary medications?
If yes, please specify:
request
Continuation
of therapy
request
What medication(s) has the member tried and failed for this diagnosis? Please specify below.
Turn-Around Time for Review
_____________________________________________________
Urgent – waiting 24 hours for a standard decision could seriously harm life, health,
or ability to regain maximum function, you can ask for an expedited decision.
Signature:
Member has a confirmed diagnosis of major
depressive disorder as defined by the DSM-V
criteria and is treatment resistant?
Spravato is prescribed by or in consultation
with a psychiatric provider?
Member does not have an active substance
use disorder (SUD)?
Member has an active substance use
disorder and the member is currently
Has member experienced an inadequate response during the current
depressive episode with the following therapies? TWO
antidepressants from at least TWO different classes having different
mechanisms of action at the maximally tolerated labeled dose, each
used for at least 4 – 6 weeks? (check any that apply)
AHCCCS preferred buprenorphine
Has member experienced an inadequate response during the current
depressive episode with at least TWO augmentation therapies for at
least 4 weeks? (check any that apply)
SSRI or SNRI and a second-generation antipsychotic used
concomitantly (aripiprazole, quetiapine, risperidone,
SSRI or SNRI and lithium used concomitantly
SSRI or SNRI and liothyronine (T3) used concomitantly
SSRI or SNRI and mirtazapine
Effective: 07/22/2020 C17690-A 06-2020 Page 1 of 2
click to sign
signature
click to edit